Ünal Ataş

14PUBLICATIONS
135CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cardiology (incl. cardiovascular diseases)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 25, 2026
Eltrombopag for Chemotherapy-Induced Thrombocytopenia: A Multicenter Retrospective Real-World Study.

|May 27, 2026
JC Virus Reactivation Should Be Considered in Late Neurotoxicity Associated with Bispecific Antibody Therapy: A Comment. Comment on Bangolo et al. Comprehensive Review of Early and Late Toxicities in CAR T-Cell Therapy and Bispecific Antibody Treatments for Hematologic Malignancies. Cancers 2025, 17, 282.

|Jan 28, 2026
Progressive multifocal leukoencephalopathy associated with elranatamab therapy in relapsed/refractory multiple myeloma.

Tansuhan Çetiner, Merve Çağla Bilek, Selin Arslan Kirezli

|Jan 28, 2026
The Role of Therapeutic Plasma Exchange in the Management of Myeloma-Related Cast Nephropathy: A 10-Year Real-World Cohort Study.

Hasan Salur, Unal Atas, Nurcan Alhan

|Oct 29, 2025
Clinical Characteristics, Treatment Approaches, and Survival Predictors in Adult Acute Myeloid Leukemia: Interim Results from the Turkish Society of Hematology AML Registry.

Volkan Karakus, Ibrahim Ethem Pinar, Utku Iltar

|Oct 29, 2025
Real-World Outcomes of Antifungal Prophylaxis in Adult Acute Lymphoblastic Leukemia Patients: A Multicenter Comparison of the Use of Fluconazole and Micafungin.

Unal Atas, Utku Iltar, Orhan Kemal Yucel

Pageof 3

Frequent Collaborators

9 joint publications

Utku Iltar

6 joint publications

Ömür Gökmen Sevindik

5 joint publications

Volkan Karakus

5 joint publications

Fahir Özkalemkaş